Journal List > J Korean Ophthalmol Soc > v.49(11) > 1008131

Chang, Song, and Sung: Comparison of Results of Cryopexy and Laser Indirect Ophthalmoscopy in Rhegmatogenous Retinal Detachment

Abstract

Purpose

To compare the efficacy and safety of intraoperative laser indirect ophthalmoscopy and cryopexy for rhegmatogenous retinal detachment through the use.

Methods

We retrospectively analyze the clinical results of 60 patients (61 eyes) with rhegmatogenous retinal detachment. All eyes had an attached macula and were scheduled for conventional scleral buckling surgery with cryopexy (25 eyes) or laser indirect ophthalmoscopy (36 eyes) from March 2001 to August 2007. The visual acuities of the two groups at the first postoperative day, 1 week, 1 month, and 3 months were compared. Retinal reattachment, macular pucker, cystoid macular edema, and proliferative vitreoretinopathy were confirmed 3 months after surgery.

Results

The visual recovery was faster in patients who received laser indirect ophthalmoscopy (1 day, P=0.044; 1 week, P=0.017). During the follow-up period, anatomical failure in the laser indirect ophthalmoscopy group did not develop, but there were two anatomical failures in the cryopexy group. In addition, 1 PVR was detected in the cryopexy group. However, neither group exhibited macular pucker or cystoid macular edema. Postoperative additional laser photocoagulation was performed on 7 eyes (19.4%) in thelaser indirect ophthalmoscopy group and 2 eyes (4.0%) in the cryopexy group.

Conclusions

Although intraoperative laser indirect ophthalmoscopy causes less chorioretinal scar formation than cryopexy, it has a higher anatomical success rate and allows for faster visual recovery.

References

1. Chignell A. Retinal detachment surgery without cryotherapy. Trans Ophthalmol Soc U K. 1997; 97:30–2.
crossref
2. Fetkenhour CL, Hauch TL. Scleral buckling without thermal adhesion. Am J Ophthalmol. 1980; 89:662–6.
crossref
3. Sabates NR, Sabates FN, Sabates R, et al. Macular detachment after retinal detachment surgery. Am J Ophthalmol. 1989; 108:22–9.
4. Appiah AP, Hirose T. Secondary causes of premacular fibrosis. Ophthalmology. 1989; 96:389–92.
crossref
5. Lobes LA Jr, Grand G. Incidence of cystoid macular edema following scleral buckling procedure. Arch Ophthalmol. 1980; 98:1230–2.
crossref
6. Lobes LA Jr, Burton TC. The incidence of macular pucker after retinal detachment surgery. Am J Ophthalmol. 1978; 85:72–7.
crossref
7. Bonnet M, Guenoun S. Surgical risk factors for severe postoperative proliferative vitreoretinopathy (PVR) in retinal detachment with grade B PVR. Grafes Arch Clin Exp Ophthalmol. 1995; 233:789–91.
crossref
8. Machemer R, Aaberg TM, Freeman HM, et al. An updated classification of retinal detachment with proliferative vitreo- retinopathy. Am J Ophthalmol. 1991; 112:159–65.
9. Arrindel EL, Wu JC, Wolf MD, et al. High resolution magnetic resonance imaging evaluation of blood-retinal barrier integrity following transscleral diode laser treatment. Arch Ophthalmol. 1995; 113:96–102.
10. Barnes SD, LoRusso FJ. Does transscleral diode laser retinopexy enhance dispersion of viable retinal pigment epithelial cells? Invest Ophthalmol Vis Sci. 1998; 39:s108.
11. Sato Y, Berkowitz BA, Wilson CA, De Juan E Jr. Blood- retinal barrier breakdown caused by diode versus argon laser endophotocoagulation. Arch Ophthalmol. 1992; 110:277–81.
12. McHugh DA, Schwartz S, Hamilton PA, et al. Diode laser contact transscleral retinal photocoagulation: a clinical study. Br J Ophthalmol. 1995; 79:1083–7.
crossref
13. Haller JA, Blair N, de Juan E Jr, et al. Transscleral diode laser retinopexy in retinal detachment surgery: results of a multicenter trial. Retina. 1998; 18:399–404.
crossref
14. Jennings T, Fuller T, Vukich JA, et al. Transscleral contact retinal photocoagulation with an 810nm semiconductor diode laser. Ophthalmic Surg. 1990; 21:492–6.
crossref
15. Arrindel EL, Wu JC, Wolf MD, et al. MRI evaluation of blood-retinal barrier following transconjunctival diode laser photocoagulation and retinal cryotherapy. Invest Ophthalmol Vis Sci. 1992; 33:S1125.
16. Steel DH, West J, Campbell WG. A randomized controlled study of the use of transscleral diode laser and cryotherapy in the management of rhegmatogenous retinal detachment. Retina. 2000; 20:346–57.
crossref
17. Veckeneer M, Van Overdam K, Bouwens D, et al. Rando- mized clinical trial of cryotherapy versus laser photo- coagulation for retinopexy in conventional retinal detachment surgery. Am J Ophthalmol. 2001; 32:343–7.
18. Cowley M, Con Wey BP, Campochiaro PA, et al. Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol. 1989; 107:1147–51.
crossref
19. Grizzard WS, Hilton GF, Hammer ME, Taren D. A multi- variate analysis of anatomic success of retinal detachments treated with scleral buckling. Grafes Arch Clin Exp Ophthalmol. 1994; 232:1–7.
20. Tseng W, Cortez RT, Ramirez G, et al. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreo- retinal surgery. Am J Ophthalmol. 2004; 137:1105–15.
21. Avitabile T, Bartolotta G, Torrisi B, Reibaldi A. A randomized prospective study of rhegmatogenous retinal detachment cases treated with cryopexy versus frequency-doubled Nd:YAG laser-retinopexy during episcleral surgery. Retina. 2004; 24:878–82.
crossref
22. Mietz H, Hiemann K. Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease. Br J Ophthal- mol. 1995; 79:874–7.
crossref
23. Burton RL, Cairns JD, Campbell WG, et al. Needle drainage of subretinal fluid. A randomized clinical trial. Retina. 1993; 13:13–6.
24. Salicone A, Smiddy WE, Venkatraman A, Feuer W. Visual recovery after scleral buckling procedure for retinal detachment. Ophthalmology. 2006; 113:1734–42.
crossref
25. Benner JD, Huang M, Morse LS, et al. Comparison of photocoagulation with argon, krypton, and diode laser indirect ophthalmoscopes in rabbit eyes. Ophthalmology. 1992; 99:1554–63.
26. Lee SH, Chang MH, Choi WS. Clinical analysis of laser photocoagulation following scleral buckling for the treatment of rhegmatogenous retinal detachment. J Korean Ophthalmol Soc. 1999; 40:3111–6.

Figure 1.
Visual recovery. LIO=laser indirect ophthalmoscopy; CRYO=Cryopexy; logMAR VA=logarithm of minimal angle of resolution visual acuity; preop=before surgery; wks=weeks; mons=months.
jkos-49-1779f1.tif
Table 1.
Preoperative and perioperative features of two study groups with rhegmatogenous retinal detachment
Characteristics LIO* group (n=36) Cryo group (n=25 ) P value Test type
Mean age, yr (mean±SD ) 31.92±11.27 36.88±13.41 0.176 Mann-Whitney test
Sex (M/F) 17/19 12/13 0.952 Pearson chi-square test
IOP(Mean±SD) 15.31±2.69 16.08±2.75 0.220 Mann-Whitney test
R.E§ (mean±SD) -5.38±5.71 -4.92±4.23 0.626 Mann-Whitney test
P/PS#/AP# 34/0/2 23/2/0 0.763 Chi-square test (linear-by-linear association)

* LIO=laser indirect ophthalmoscopy

Cryo=cryopexy

IOP=intraocular pressure

§ R.E=refractive error

P=phakic

# PS= pseudophakic

** AP=aphakic.

Table 2.
LogMAR visual acuity before and after surgery (Mann-Whitney test, P<0.05)
LIO* group (mean±SD) Cryo group (mean±SD) P-value
Before surgery 0.15±0.17 0.20±0.31 0.967
Day 1 0.49±0.46 0.64±0.34 0.044
Day 7 0.23±0.28 0.31±0.21 0.017
4 weeks 0.11±0.16 0.12±0.13 0.342
3 months 0.04±0.10 0.04±0.07 0.369

* LIO=laser indirect ophthalmoscopy

Cryo=cryopexy.

Table 3.
Influence of intravitreal SF6 gas injection and subretinal fluid drainage on postoperative visual acuity ( P value)
Day 1 Day 7 4 wks 3 mons#
SF6* gas in LIO(n=6) 0.606 0.258 0.140 0.350
SRFD in Cryo§ (n=5) 0.055 0.757 0.482 0.169

* SF6=sulfur hexafluoride

LIO=laser indirect ophthalmoscopy

SRFD=subretinal fluid drainage

§ Cryo=cryopexy

wks= weeks

# mons=months; Mann-Whitney test, P<0.05.

TOOLS
Similar articles